nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—MPO—chronic obstructive pulmonary disease	0.422	1	CbGaD
Mesalazine—ALOX5—Montelukast—chronic obstructive pulmonary disease	0.26	0.817	CbGbCtD
Mesalazine—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0584	0.184	CbGbCtD
Mesalazine—PPARG—leg—chronic obstructive pulmonary disease	0.00505	0.127	CbGeAlD
Mesalazine—CHUK—connective tissue—chronic obstructive pulmonary disease	0.00261	0.0655	CbGeAlD
Mesalazine—PTGS2—leg—chronic obstructive pulmonary disease	0.00258	0.0647	CbGeAlD
Mesalazine—IKBKB—respiratory system—chronic obstructive pulmonary disease	0.00202	0.0506	CbGeAlD
Mesalazine—IKBKB—connective tissue—chronic obstructive pulmonary disease	0.00177	0.0445	CbGeAlD
Mesalazine—ALOX5—respiratory system—chronic obstructive pulmonary disease	0.00167	0.0419	CbGeAlD
Mesalazine—IKBKB—bronchus—chronic obstructive pulmonary disease	0.00166	0.0416	CbGeAlD
Mesalazine—IKBKB—smooth muscle tissue—chronic obstructive pulmonary disease	0.00162	0.0407	CbGeAlD
Mesalazine—CHUK—lung—chronic obstructive pulmonary disease	0.00157	0.0395	CbGeAlD
Mesalazine—ALOX5—connective tissue—chronic obstructive pulmonary disease	0.00147	0.0369	CbGeAlD
Mesalazine—MPO—respiratory system—chronic obstructive pulmonary disease	0.00141	0.0355	CbGeAlD
Mesalazine—ALOX5—bronchus—chronic obstructive pulmonary disease	0.00137	0.0345	CbGeAlD
Mesalazine—ALOX5—smooth muscle tissue—chronic obstructive pulmonary disease	0.00134	0.0337	CbGeAlD
Mesalazine—PPARG—respiratory system—chronic obstructive pulmonary disease	0.00125	0.0315	CbGeAlD
Mesalazine—MPO—connective tissue—chronic obstructive pulmonary disease	0.00124	0.0312	CbGeAlD
Mesalazine—PPARG—connective tissue—chronic obstructive pulmonary disease	0.0011	0.0277	CbGeAlD
Mesalazine—IKBKB—lung—chronic obstructive pulmonary disease	0.00107	0.0268	CbGeAlD
Mesalazine—PPARG—smooth muscle tissue—chronic obstructive pulmonary disease	0.00101	0.0253	CbGeAlD
Mesalazine—Aminosalicylic Acid—MPO—chronic obstructive pulmonary disease	0.000928	0.401	CrCbGaD
Mesalazine—ALOX5—lung—chronic obstructive pulmonary disease	0.000887	0.0223	CbGeAlD
Mesalazine—MPO—lung—chronic obstructive pulmonary disease	0.00075	0.0188	CbGeAlD
Mesalazine—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.00067	0.0168	CbGeAlD
Mesalazine—PPARG—lung—chronic obstructive pulmonary disease	0.000666	0.0167	CbGeAlD
Mesalazine—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000641	0.0161	CbGeAlD
Mesalazine—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.00059	0.0148	CbGeAlD
Mesalazine—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000564	0.0142	CbGeAlD
Mesalazine—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00054	0.0135	CbGeAlD
Mesalazine—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000527	0.0132	CbGeAlD
Mesalazine—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000516	0.0129	CbGeAlD
Mesalazine—PTGS1—trachea—chronic obstructive pulmonary disease	0.000495	0.0124	CbGeAlD
Mesalazine—PTGS2—trachea—chronic obstructive pulmonary disease	0.000474	0.0119	CbGeAlD
Mesalazine—Droxidopa—ADRB2—chronic obstructive pulmonary disease	0.000384	0.166	CrCbGaD
Mesalazine—PTGS1—lung—chronic obstructive pulmonary disease	0.000356	0.00893	CbGeAlD
Mesalazine—PTGS2—lung—chronic obstructive pulmonary disease	0.00034	0.00854	CbGeAlD
Mesalazine—Diflunisal—ALB—chronic obstructive pulmonary disease	0.00031	0.134	CrCbGaD
Mesalazine—Dopamine—SLC6A4—chronic obstructive pulmonary disease	0.000273	0.118	CrCbGaD
Mesalazine—Dopamine—CYP1A2—chronic obstructive pulmonary disease	0.000248	0.107	CrCbGaD
Mesalazine—Salicylic acid—ALB—chronic obstructive pulmonary disease	0.000172	0.0744	CrCbGaD
Mesalazine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.000878	CcSEcCtD
Mesalazine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000119	0.000878	CcSEcCtD
Mesalazine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000871	CcSEcCtD
Mesalazine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000871	CcSEcCtD
Mesalazine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000871	CcSEcCtD
Mesalazine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000118	0.00087	CcSEcCtD
Mesalazine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000868	CcSEcCtD
Mesalazine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000867	CcSEcCtD
Mesalazine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000867	CcSEcCtD
Mesalazine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000117	0.000866	CcSEcCtD
Mesalazine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000866	CcSEcCtD
Mesalazine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000866	CcSEcCtD
Mesalazine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000863	CcSEcCtD
Mesalazine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000863	CcSEcCtD
Mesalazine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00086	CcSEcCtD
Mesalazine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000117	0.00086	CcSEcCtD
Mesalazine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000859	CcSEcCtD
Mesalazine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000859	CcSEcCtD
Mesalazine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000116	0.000856	CcSEcCtD
Mesalazine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000852	CcSEcCtD
Mesalazine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000849	CcSEcCtD
Mesalazine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000848	CcSEcCtD
Mesalazine—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000848	CcSEcCtD
Mesalazine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000841	CcSEcCtD
Mesalazine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000835	CcSEcCtD
Mesalazine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000835	CcSEcCtD
Mesalazine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000829	CcSEcCtD
Mesalazine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000826	CcSEcCtD
Mesalazine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000826	CcSEcCtD
Mesalazine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000825	CcSEcCtD
Mesalazine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000111	0.000822	CcSEcCtD
Mesalazine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000821	CcSEcCtD
Mesalazine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000819	CcSEcCtD
Mesalazine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000815	CcSEcCtD
Mesalazine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000811	CcSEcCtD
Mesalazine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000109	0.000807	CcSEcCtD
Mesalazine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.000807	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000805	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000805	CcSEcCtD
Mesalazine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000108	0.0008	CcSEcCtD
Mesalazine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.0008	CcSEcCtD
Mesalazine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000796	CcSEcCtD
Mesalazine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000108	0.000795	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000107	0.000789	CcSEcCtD
Mesalazine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000788	CcSEcCtD
Mesalazine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000788	CcSEcCtD
Mesalazine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000786	CcSEcCtD
Mesalazine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000786	CcSEcCtD
Mesalazine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000783	CcSEcCtD
Mesalazine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00078	CcSEcCtD
Mesalazine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.000778	CcSEcCtD
Mesalazine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000105	0.000778	CcSEcCtD
Mesalazine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000778	CcSEcCtD
Mesalazine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000105	0.000775	CcSEcCtD
Mesalazine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000104	0.00077	CcSEcCtD
Mesalazine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000104	0.000768	CcSEcCtD
Mesalazine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000766	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000763	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000763	CcSEcCtD
Mesalazine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000103	0.000762	CcSEcCtD
Mesalazine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000762	CcSEcCtD
Mesalazine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000762	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000761	CcSEcCtD
Mesalazine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000756	CcSEcCtD
Mesalazine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000756	CcSEcCtD
Mesalazine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000756	CcSEcCtD
Mesalazine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000756	CcSEcCtD
Mesalazine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000755	CcSEcCtD
Mesalazine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000753	CcSEcCtD
Mesalazine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.00075	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000748	CcSEcCtD
Mesalazine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000747	CcSEcCtD
Mesalazine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000744	CcSEcCtD
Mesalazine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000742	CcSEcCtD
Mesalazine—Pain—Montelukast—chronic obstructive pulmonary disease	0.0001	0.00074	CcSEcCtD
Mesalazine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.0001	0.000739	CcSEcCtD
Mesalazine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	9.97e-05	0.000736	CcSEcCtD
Mesalazine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	9.96e-05	0.000735	CcSEcCtD
Mesalazine—Rash—Aminophylline—chronic obstructive pulmonary disease	9.93e-05	0.000732	CcSEcCtD
Mesalazine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	9.92e-05	0.000732	CcSEcCtD
Mesalazine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	9.89e-05	0.00073	CcSEcCtD
Mesalazine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	9.87e-05	0.000729	CcSEcCtD
Mesalazine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	9.87e-05	0.000729	CcSEcCtD
Mesalazine—Headache—Aminophylline—chronic obstructive pulmonary disease	9.86e-05	0.000728	CcSEcCtD
Mesalazine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	9.83e-05	0.000726	CcSEcCtD
Mesalazine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	9.82e-05	0.000724	CcSEcCtD
Mesalazine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	9.8e-05	0.000723	CcSEcCtD
Mesalazine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	9.8e-05	0.000723	CcSEcCtD
Mesalazine—Lethargy—Prednisone—chronic obstructive pulmonary disease	9.79e-05	0.000722	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	9.77e-05	0.000721	CcSEcCtD
Mesalazine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	9.75e-05	0.00072	CcSEcCtD
Mesalazine—Constipation—Salbutamol—chronic obstructive pulmonary disease	9.67e-05	0.000714	CcSEcCtD
Mesalazine—Pain—Salbutamol—chronic obstructive pulmonary disease	9.67e-05	0.000714	CcSEcCtD
Mesalazine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	9.6e-05	0.000708	CcSEcCtD
Mesalazine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	9.59e-05	0.000708	CcSEcCtD
Mesalazine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.59e-05	0.000708	CcSEcCtD
Mesalazine—Urticaria—Formoterol—chronic obstructive pulmonary disease	9.52e-05	0.000702	CcSEcCtD
Mesalazine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	9.52e-05	0.000702	CcSEcCtD
Mesalazine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	9.47e-05	0.000699	CcSEcCtD
Mesalazine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	9.47e-05	0.000699	CcSEcCtD
Mesalazine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	9.47e-05	0.000699	CcSEcCtD
Mesalazine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	9.47e-05	0.000699	CcSEcCtD
Mesalazine—Affect lability—Prednisone—chronic obstructive pulmonary disease	9.44e-05	0.000697	CcSEcCtD
Mesalazine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	9.44e-05	0.000697	CcSEcCtD
Mesalazine—Rash—Tiotropium—chronic obstructive pulmonary disease	9.36e-05	0.000691	CcSEcCtD
Mesalazine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	9.35e-05	0.00069	CcSEcCtD
Mesalazine—Nausea—Aminophylline—chronic obstructive pulmonary disease	9.35e-05	0.00069	CcSEcCtD
Mesalazine—Urticaria—Montelukast—chronic obstructive pulmonary disease	9.32e-05	0.000688	CcSEcCtD
Mesalazine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	9.32e-05	0.000688	CcSEcCtD
Mesalazine—Headache—Tiotropium—chronic obstructive pulmonary disease	9.3e-05	0.000686	CcSEcCtD
Mesalazine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	9.28e-05	0.000685	CcSEcCtD
Mesalazine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	9.28e-05	0.000685	CcSEcCtD
Mesalazine—Face oedema—Prednisone—chronic obstructive pulmonary disease	9.26e-05	0.000683	CcSEcCtD
Mesalazine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	9.25e-05	0.000683	CcSEcCtD
Mesalazine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	9.18e-05	0.000677	CcSEcCtD
Mesalazine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	9.13e-05	0.000674	CcSEcCtD
Mesalazine—Mood swings—Prednisone—chronic obstructive pulmonary disease	9.09e-05	0.000671	CcSEcCtD
Mesalazine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	8.99e-05	0.000663	CcSEcCtD
Mesalazine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	8.94e-05	0.00066	CcSEcCtD
Mesalazine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	8.94e-05	0.00066	CcSEcCtD
Mesalazine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	8.83e-05	0.000651	CcSEcCtD
Mesalazine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	8.83e-05	0.000651	CcSEcCtD
Mesalazine—Nausea—Tiotropium—chronic obstructive pulmonary disease	8.82e-05	0.000651	CcSEcCtD
Mesalazine—Dry skin—Prednisone—chronic obstructive pulmonary disease	8.79e-05	0.000649	CcSEcCtD
Mesalazine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	8.65e-05	0.000638	CcSEcCtD
Mesalazine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	8.6e-05	0.000634	CcSEcCtD
Mesalazine—Asthenia—Formoterol—chronic obstructive pulmonary disease	8.6e-05	0.000634	CcSEcCtD
Mesalazine—Pruritus—Formoterol—chronic obstructive pulmonary disease	8.48e-05	0.000625	CcSEcCtD
Mesalazine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	8.48e-05	0.000625	CcSEcCtD
Mesalazine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	8.46e-05	0.000624	CcSEcCtD
Mesalazine—Asthenia—Montelukast—chronic obstructive pulmonary disease	8.42e-05	0.000621	CcSEcCtD
Mesalazine—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	8.35e-05	0.000616	CcSEcCtD
Mesalazine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	8.34e-05	0.000615	CcSEcCtD
Mesalazine—Pruritus—Montelukast—chronic obstructive pulmonary disease	8.3e-05	0.000613	CcSEcCtD
Mesalazine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	8.2e-05	0.000605	CcSEcCtD
Mesalazine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	8.2e-05	0.000605	CcSEcCtD
Mesalazine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.0006	CcSEcCtD
Mesalazine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	8.12e-05	0.000599	CcSEcCtD
Mesalazine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	8.03e-05	0.000592	CcSEcCtD
Mesalazine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	8e-05	0.000591	CcSEcCtD
Mesalazine—Erythema—Prednisolone—chronic obstructive pulmonary disease	7.95e-05	0.000587	CcSEcCtD
Mesalazine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	7.92e-05	0.000585	CcSEcCtD
Mesalazine—Dizziness—Formoterol—chronic obstructive pulmonary disease	7.92e-05	0.000585	CcSEcCtD
Mesalazine—Dizziness—Montelukast—chronic obstructive pulmonary disease	7.76e-05	0.000573	CcSEcCtD
Mesalazine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.000572	CcSEcCtD
Mesalazine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	7.74e-05	0.000571	CcSEcCtD
Mesalazine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	7.62e-05	0.000562	CcSEcCtD
Mesalazine—Vomiting—Formoterol—chronic obstructive pulmonary disease	7.62e-05	0.000562	CcSEcCtD
Mesalazine—Rash—Formoterol—chronic obstructive pulmonary disease	7.55e-05	0.000557	CcSEcCtD
Mesalazine—Rash—Arformoterol—chronic obstructive pulmonary disease	7.55e-05	0.000557	CcSEcCtD
Mesalazine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	7.55e-05	0.000557	CcSEcCtD
Mesalazine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	7.55e-05	0.000557	CcSEcCtD
Mesalazine—Weight increased—Prednisone—chronic obstructive pulmonary disease	7.55e-05	0.000557	CcSEcCtD
Mesalazine—Headache—Arformoterol—chronic obstructive pulmonary disease	7.51e-05	0.000554	CcSEcCtD
Mesalazine—Headache—Formoterol—chronic obstructive pulmonary disease	7.51e-05	0.000554	CcSEcCtD
Mesalazine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	7.5e-05	0.000554	CcSEcCtD
Mesalazine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	7.49e-05	0.000553	CcSEcCtD
Mesalazine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	7.48e-05	0.000552	CcSEcCtD
Mesalazine—Vomiting—Montelukast—chronic obstructive pulmonary disease	7.46e-05	0.000551	CcSEcCtD
Mesalazine—Rash—Montelukast—chronic obstructive pulmonary disease	7.4e-05	0.000546	CcSEcCtD
Mesalazine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	7.39e-05	0.000545	CcSEcCtD
Mesalazine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	7.38e-05	0.000544	CcSEcCtD
Mesalazine—Depression—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.000544	CcSEcCtD
Mesalazine—Headache—Montelukast—chronic obstructive pulmonary disease	7.35e-05	0.000542	CcSEcCtD
Mesalazine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	7.26e-05	0.000536	CcSEcCtD
Mesalazine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	7.25e-05	0.000535	CcSEcCtD
Mesalazine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	7.19e-05	0.000531	CcSEcCtD
Mesalazine—Malaise—Prednisolone—chronic obstructive pulmonary disease	7.17e-05	0.000529	CcSEcCtD
Mesalazine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	7.14e-05	0.000527	CcSEcCtD
Mesalazine—Rash—Salbutamol—chronic obstructive pulmonary disease	7.13e-05	0.000526	CcSEcCtD
Mesalazine—Syncope—Prednisolone—chronic obstructive pulmonary disease	7.13e-05	0.000526	CcSEcCtD
Mesalazine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	7.13e-05	0.000526	CcSEcCtD
Mesalazine—Nausea—Formoterol—chronic obstructive pulmonary disease	7.12e-05	0.000525	CcSEcCtD
Mesalazine—Nausea—Arformoterol—chronic obstructive pulmonary disease	7.12e-05	0.000525	CcSEcCtD
Mesalazine—Headache—Salbutamol—chronic obstructive pulmonary disease	7.09e-05	0.000523	CcSEcCtD
Mesalazine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	6.99e-05	0.000516	CcSEcCtD
Mesalazine—Nausea—Montelukast—chronic obstructive pulmonary disease	6.97e-05	0.000514	CcSEcCtD
Mesalazine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	6.86e-05	0.000506	CcSEcCtD
Mesalazine—Nausea—Salbutamol—chronic obstructive pulmonary disease	6.72e-05	0.000496	CcSEcCtD
Mesalazine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	6.69e-05	0.000493	CcSEcCtD
Mesalazine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	6.67e-05	0.000492	CcSEcCtD
Mesalazine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	6.64e-05	0.00049	CcSEcCtD
Mesalazine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	6.52e-05	0.000481	CcSEcCtD
Mesalazine—Oedema—Prednisolone—chronic obstructive pulmonary disease	6.49e-05	0.000479	CcSEcCtD
Mesalazine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	6.49e-05	0.000479	CcSEcCtD
Mesalazine—Shock—Prednisolone—chronic obstructive pulmonary disease	6.38e-05	0.000471	CcSEcCtD
Mesalazine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.33e-05	0.000467	CcSEcCtD
Mesalazine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6.27e-05	0.000463	CcSEcCtD
Mesalazine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	6.2e-05	0.000458	CcSEcCtD
Mesalazine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.000444	CcSEcCtD
Mesalazine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	5.99e-05	0.000442	CcSEcCtD
Mesalazine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	5.87e-05	0.000433	CcSEcCtD
Mesalazine—Alopecia—Prednisone—chronic obstructive pulmonary disease	5.86e-05	0.000433	CcSEcCtD
Mesalazine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	5.83e-05	0.00043	CcSEcCtD
Mesalazine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000429	CcSEcCtD
Mesalazine—Erythema—Prednisone—chronic obstructive pulmonary disease	5.78e-05	0.000426	CcSEcCtD
Mesalazine—Pain—Prednisolone—chronic obstructive pulmonary disease	5.55e-05	0.000409	CcSEcCtD
Mesalazine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.000402	CcSEcCtD
Mesalazine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	5.36e-05	0.000396	CcSEcCtD
Mesalazine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.35e-05	0.000395	CcSEcCtD
Mesalazine—Anaemia—Prednisone—chronic obstructive pulmonary disease	5.34e-05	0.000394	CcSEcCtD
Mesalazine—Angioedema—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.00039	CcSEcCtD
Mesalazine—Malaise—Prednisone—chronic obstructive pulmonary disease	5.21e-05	0.000384	CcSEcCtD
Mesalazine—Vertigo—Prednisone—chronic obstructive pulmonary disease	5.19e-05	0.000383	CcSEcCtD
Mesalazine—Syncope—Prednisone—chronic obstructive pulmonary disease	5.18e-05	0.000382	CcSEcCtD
Mesalazine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.15e-05	0.00038	CcSEcCtD
Mesalazine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	5.08e-05	0.000375	CcSEcCtD
Mesalazine—Hypertension—Prednisone—chronic obstructive pulmonary disease	4.99e-05	0.000368	CcSEcCtD
Mesalazine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000363	CcSEcCtD
Mesalazine—Myalgia—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000363	CcSEcCtD
Mesalazine—Anxiety—Prednisone—chronic obstructive pulmonary disease	4.9e-05	0.000362	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	4.88e-05	0.00036	CcSEcCtD
Mesalazine—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.86e-05	0.000359	CcSEcCtD
Mesalazine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.78e-05	0.000353	CcSEcCtD
Mesalazine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4.72e-05	0.000348	CcSEcCtD
Mesalazine—Oedema—Prednisone—chronic obstructive pulmonary disease	4.72e-05	0.000348	CcSEcCtD
Mesalazine—Infection—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.000346	CcSEcCtD
Mesalazine—Shock—Prednisone—chronic obstructive pulmonary disease	4.64e-05	0.000342	CcSEcCtD
Mesalazine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	4.62e-05	0.000341	CcSEcCtD
Mesalazine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.6e-05	0.00034	CcSEcCtD
Mesalazine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	4.58e-05	0.000338	CcSEcCtD
Mesalazine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.56e-05	0.000336	CcSEcCtD
Mesalazine—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.49e-05	0.000332	CcSEcCtD
Mesalazine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—chronic obstructive pulmonary disease	4.4e-05	0.000539	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—IL6—chronic obstructive pulmonary disease	4.4e-05	0.000539	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GCLC—chronic obstructive pulmonary disease	4.37e-05	0.000535	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	4.33e-05	0.00053	CbGpPWpGaD
Mesalazine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—chronic obstructive pulmonary disease	4.32e-05	0.000529	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	4.32e-05	0.000529	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—TLR2—chronic obstructive pulmonary disease	4.3e-05	0.000527	CbGpPWpGaD
Mesalazine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.3e-05	0.000317	CcSEcCtD
Mesalazine—CHUK—Downstream signaling of activated FGFR—EGFR—chronic obstructive pulmonary disease	4.29e-05	0.000526	CbGpPWpGaD
Mesalazine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.29e-05	0.000317	CcSEcCtD
Mesalazine—CHUK—Adaptive Immune System—KL—chronic obstructive pulmonary disease	4.28e-05	0.000524	CbGpPWpGaD
Mesalazine—CHUK—Signaling by Interleukins—IL6—chronic obstructive pulmonary disease	4.27e-05	0.000522	CbGpPWpGaD
Mesalazine—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.26e-05	0.000315	CcSEcCtD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.25e-05	0.00052	CbGpPWpGaD
Mesalazine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.23e-05	0.000312	CcSEcCtD
Mesalazine—CHUK—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	4.22e-05	0.000517	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	4.19e-05	0.000513	CbGpPWpGaD
Mesalazine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.15e-05	0.000306	CcSEcCtD
Mesalazine—IKBKB—MyD88-independent cascade—IL6—chronic obstructive pulmonary disease	4.15e-05	0.000508	CbGpPWpGaD
Mesalazine—CHUK—Activated TLR4 signalling—IL6—chronic obstructive pulmonary disease	4.12e-05	0.000504	CbGpPWpGaD
Mesalazine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.1e-05	0.000302	CcSEcCtD
Mesalazine—Rash—Prednisolone—chronic obstructive pulmonary disease	4.09e-05	0.000302	CcSEcCtD
Mesalazine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.09e-05	0.000302	CcSEcCtD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.08e-05	0.000499	CbGpPWpGaD
Mesalazine—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.07e-05	0.0003	CcSEcCtD
Mesalazine—Headache—Prednisolone—chronic obstructive pulmonary disease	4.07e-05	0.0003	CcSEcCtD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	4.05e-05	0.000496	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.05e-05	0.000495	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—KL—chronic obstructive pulmonary disease	4.04e-05	0.000495	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—EGFR—chronic obstructive pulmonary disease	4.03e-05	0.000494	CbGpPWpGaD
Mesalazine—Constipation—Prednisone—chronic obstructive pulmonary disease	4.03e-05	0.000298	CcSEcCtD
Mesalazine—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	4.02e-05	0.000492	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—EGFR—chronic obstructive pulmonary disease	4.01e-05	0.000491	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—EGFR—chronic obstructive pulmonary disease	4e-05	0.000489	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CTGF—chronic obstructive pulmonary disease	3.99e-05	0.000489	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—EGFR—chronic obstructive pulmonary disease	3.98e-05	0.000487	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—IL6—chronic obstructive pulmonary disease	3.92e-05	0.00048	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	3.92e-05	0.00048	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—chronic obstructive pulmonary disease	3.92e-05	0.00048	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.91e-05	0.000479	CbGpPWpGaD
Mesalazine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.89e-05	0.000287	CcSEcCtD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.89e-05	0.000476	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—KL—chronic obstructive pulmonary disease	3.88e-05	0.000475	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—chronic obstructive pulmonary disease	3.87e-05	0.000474	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—IL6—chronic obstructive pulmonary disease	3.87e-05	0.000474	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.86e-05	0.000284	CcSEcCtD
Mesalazine—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.85e-05	0.000284	CcSEcCtD
Mesalazine—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	3.79e-05	0.000464	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.75e-05	0.000459	CbGpPWpGaD
Mesalazine—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.75e-05	0.000276	CcSEcCtD
Mesalazine—CHUK—Signaling by FGFR in disease—EGFR—chronic obstructive pulmonary disease	3.74e-05	0.000458	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—chronic obstructive pulmonary disease	3.74e-05	0.000458	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—EGFR—chronic obstructive pulmonary disease	3.74e-05	0.000458	CbGpPWpGaD
Mesalazine—IKBKB—Activated TLR4 signalling—IL6—chronic obstructive pulmonary disease	3.73e-05	0.000457	CbGpPWpGaD
Mesalazine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.73e-05	0.000275	CcSEcCtD
Mesalazine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.73e-05	0.000275	CcSEcCtD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.71e-05	0.000455	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—EGFR—chronic obstructive pulmonary disease	3.71e-05	0.000454	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.69e-05	0.000452	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.68e-05	0.00045	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—EGFR—chronic obstructive pulmonary disease	3.67e-05	0.00045	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.67e-05	0.000449	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—EGFR—chronic obstructive pulmonary disease	3.66e-05	0.000448	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.61e-05	0.000442	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—LEP—chronic obstructive pulmonary disease	3.61e-05	0.000442	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	3.61e-05	0.000442	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.59e-05	0.000439	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.58e-05	0.000438	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.57e-05	0.000437	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—chronic obstructive pulmonary disease	3.55e-05	0.000435	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—EGFR—chronic obstructive pulmonary disease	3.54e-05	0.000433	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.52e-05	0.000431	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	3.51e-05	0.00043	CbGpPWpGaD
Mesalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—chronic obstructive pulmonary disease	3.51e-05	0.00043	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	3.49e-05	0.000427	CbGpPWpGaD
Mesalazine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.47e-05	0.000256	CcSEcCtD
Mesalazine—CHUK—B Cell Activation—EGFR—chronic obstructive pulmonary disease	3.46e-05	0.000424	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	3.45e-05	0.000423	CbGpPWpGaD
Mesalazine—CHUK—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	3.45e-05	0.000422	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	3.45e-05	0.000422	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL1B—chronic obstructive pulmonary disease	3.4e-05	0.000416	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—chronic obstructive pulmonary disease	3.39e-05	0.000415	CbGpPWpGaD
Mesalazine—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.38e-05	0.00025	CcSEcCtD
Mesalazine—IKBKB—MAPK Signaling Pathway—TNF—chronic obstructive pulmonary disease	3.37e-05	0.000412	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.35e-05	0.00041	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	3.34e-05	0.000409	CbGpPWpGaD
Mesalazine—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.34e-05	0.000246	CcSEcCtD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	3.31e-05	0.000406	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	3.3e-05	0.000404	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.26e-05	0.0004	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	3.25e-05	0.000397	CbGpPWpGaD
Mesalazine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.23e-05	0.000238	CcSEcCtD
Mesalazine—CHUK—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	3.21e-05	0.000393	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.18e-05	0.000389	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	3.16e-05	0.000387	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—EGFR—chronic obstructive pulmonary disease	3.14e-05	0.000384	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	3.13e-05	0.000383	CbGpPWpGaD
Mesalazine—IKBKB—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	3.13e-05	0.000383	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	3.13e-05	0.000383	CbGpPWpGaD
Mesalazine—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.12e-05	0.00023	CcSEcCtD
Mesalazine—CHUK—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	3.1e-05	0.00038	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	3.09e-05	0.000378	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.08e-05	0.000378	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL1B—chronic obstructive pulmonary disease	3.08e-05	0.000378	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	3.07e-05	0.000376	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.07e-05	0.000375	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.07e-05	0.000375	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	3.06e-05	0.000375	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CRP—chronic obstructive pulmonary disease	3.06e-05	0.000374	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—IL6—chronic obstructive pulmonary disease	3.06e-05	0.000374	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	3.03e-05	0.000371	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.02e-05	0.00037	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.02e-05	0.00037	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	3.01e-05	0.000368	CbGpPWpGaD
Mesalazine—Vomiting—Prednisone—chronic obstructive pulmonary disease	3e-05	0.000221	CcSEcCtD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.98e-05	0.000365	CbGpPWpGaD
Mesalazine—Rash—Prednisone—chronic obstructive pulmonary disease	2.97e-05	0.000219	CcSEcCtD
Mesalazine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.97e-05	0.000219	CcSEcCtD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	2.97e-05	0.000363	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.96e-05	0.000362	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.95e-05	0.000362	CbGpPWpGaD
Mesalazine—Headache—Prednisone—chronic obstructive pulmonary disease	2.95e-05	0.000218	CcSEcCtD
Mesalazine—CHUK—Innate Immune System—TLR4—chronic obstructive pulmonary disease	2.93e-05	0.000359	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	2.92e-05	0.000357	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	2.91e-05	0.000356	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	2.87e-05	0.000352	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	2.87e-05	0.000352	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—IL6—chronic obstructive pulmonary disease	2.87e-05	0.000352	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.87e-05	0.000351	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	2.85e-05	0.000349	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.84e-05	0.000348	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	2.82e-05	0.000346	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.82e-05	0.000345	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	2.81e-05	0.000344	CbGpPWpGaD
Mesalazine—Nausea—Prednisone—chronic obstructive pulmonary disease	2.8e-05	0.000207	CcSEcCtD
Mesalazine—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	2.79e-05	0.000341	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.78e-05	0.00034	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CRP—chronic obstructive pulmonary disease	2.77e-05	0.000339	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.77e-05	0.000339	CbGpPWpGaD
Mesalazine—CHUK—Immune System—TLR2—chronic obstructive pulmonary disease	2.76e-05	0.000338	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.74e-05	0.000335	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GCLC—chronic obstructive pulmonary disease	2.71e-05	0.000331	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.67e-05	0.000327	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—TLR4—chronic obstructive pulmonary disease	2.66e-05	0.000325	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	2.61e-05	0.000319	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.6e-05	0.000318	CbGpPWpGaD
Mesalazine—CHUK—Immune System—KL—chronic obstructive pulmonary disease	2.6e-05	0.000318	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.59e-05	0.000317	CbGpPWpGaD
Mesalazine—CHUK—Disease—HDAC2—chronic obstructive pulmonary disease	2.58e-05	0.000316	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	2.57e-05	0.000315	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	2.55e-05	0.000312	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	2.55e-05	0.000312	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.52e-05	0.000309	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TLR2—chronic obstructive pulmonary disease	2.51e-05	0.000307	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.47e-05	0.000303	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CTGF—chronic obstructive pulmonary disease	2.47e-05	0.000302	CbGpPWpGaD
Mesalazine—CHUK—Disease—KL—chronic obstructive pulmonary disease	2.4e-05	0.000294	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—KL—chronic obstructive pulmonary disease	2.36e-05	0.000288	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	2.36e-05	0.000288	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.32e-05	0.000284	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	2.31e-05	0.000283	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.28e-05	0.000279	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.24e-05	0.000274	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.17e-05	0.000266	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.13e-05	0.00026	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD8A—chronic obstructive pulmonary disease	2.09e-05	0.000256	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.08e-05	0.000255	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.06e-05	0.000253	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	1.99e-05	0.000244	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.99e-05	0.000243	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—IL6—chronic obstructive pulmonary disease	1.96e-05	0.00024	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.95e-05	0.000238	CbGpPWpGaD
Mesalazine—CHUK—Immune System—ERBB3—chronic obstructive pulmonary disease	1.95e-05	0.000238	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.92e-05	0.000235	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD8A—chronic obstructive pulmonary disease	1.9e-05	0.000232	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.9e-05	0.000232	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.9e-05	0.000232	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.87e-05	0.000229	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ALB—chronic obstructive pulmonary disease	1.82e-05	0.000222	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.81e-05	0.000221	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	1.81e-05	0.000221	CbGpPWpGaD
Mesalazine—CHUK—Disease—ERBB3—chronic obstructive pulmonary disease	1.8e-05	0.00022	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.79e-05	0.000219	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CRP—chronic obstructive pulmonary disease	1.78e-05	0.000218	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—IL6—chronic obstructive pulmonary disease	1.78e-05	0.000217	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.77e-05	0.000216	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—ERBB3—chronic obstructive pulmonary disease	1.77e-05	0.000216	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.75e-05	0.000215	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.75e-05	0.000214	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.74e-05	0.000214	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.74e-05	0.000213	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.73e-05	0.000212	CbGpPWpGaD
Mesalazine—CHUK—Immune System—TLR4—chronic obstructive pulmonary disease	1.71e-05	0.000209	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.68e-05	0.000206	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.67e-05	0.000204	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.65e-05	0.000202	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.64e-05	0.000201	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CRP—chronic obstructive pulmonary disease	1.61e-05	0.000198	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.59e-05	0.000195	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.55e-05	0.00019	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TLR4—chronic obstructive pulmonary disease	1.55e-05	0.00019	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	1.53e-05	0.000187	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.52e-05	0.000186	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.52e-05	0.000186	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.51e-05	0.000184	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS2—chronic obstructive pulmonary disease	1.5e-05	0.000184	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.45e-05	0.000178	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.45e-05	0.000177	CbGpPWpGaD
Mesalazine—PTGS2—Disease—KL—chronic obstructive pulmonary disease	1.42e-05	0.000174	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.41e-05	0.000172	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.4e-05	0.000172	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	1.4e-05	0.000171	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.39e-05	0.00017	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.37e-05	0.000168	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.35e-05	0.000165	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.33e-05	0.000163	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.32e-05	0.000161	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.31e-05	0.000161	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.27e-05	0.000155	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	1.27e-05	0.000155	CbGpPWpGaD
Mesalazine—CHUK—Disease—SERPINE1—chronic obstructive pulmonary disease	1.26e-05	0.000155	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.26e-05	0.000154	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.26e-05	0.000154	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.22e-05	0.00015	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.21e-05	0.000148	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS3—chronic obstructive pulmonary disease	1.21e-05	0.000148	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000142	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.14e-05	0.00014	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.13e-05	0.000138	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ALB—chronic obstructive pulmonary disease	1.12e-05	0.000138	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.12e-05	0.000137	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1B—chronic obstructive pulmonary disease	1.11e-05	0.000136	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.1e-05	0.000135	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—NOS3—chronic obstructive pulmonary disease	1.08e-05	0.000132	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	1.07e-05	0.00013	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.06e-05	0.000129	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.04e-05	0.000127	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.02e-05	0.000125	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.01e-05	0.000124	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1B—chronic obstructive pulmonary disease	1.01e-05	0.000123	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.7e-06	0.000119	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.2e-06	0.000113	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	8.88e-06	0.000109	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.84e-06	0.000108	CbGpPWpGaD
Mesalazine—CHUK—Immune System—EGFR—chronic obstructive pulmonary disease	8.46e-06	0.000104	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.44e-06	0.000103	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.02e-06	9.81e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFB1—chronic obstructive pulmonary disease	7.97e-06	9.76e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	7.87e-06	9.64e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—EGFR—chronic obstructive pulmonary disease	7.81e-06	9.57e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—EGFR—chronic obstructive pulmonary disease	7.68e-06	9.4e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.65e-06	9.37e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.53e-06	9.22e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.49e-06	9.17e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	7.48e-06	9.16e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	7.14e-06	8.74e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.79e-06	8.31e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.77e-06	8.29e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—chronic obstructive pulmonary disease	6.51e-06	7.96e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	6.25e-06	7.65e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.14e-06	7.52e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.08e-06	7.44e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—chronic obstructive pulmonary disease	6.01e-06	7.35e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.98e-06	7.32e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—chronic obstructive pulmonary disease	5.9e-06	7.22e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.58e-06	6.83e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.51e-06	6.75e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.47e-06	6.7e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.06e-06	6.2e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.96e-06	6.07e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	4.72e-06	5.78e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	4.63e-06	5.67e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.59e-06	5.62e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.21e-06	5.15e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.17e-06	5.1e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.81e-06	4.67e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	3.56e-06	4.36e-05	CbGpPWpGaD
